20 (AIDX) Assets (2024 - 2026)

20 posted quarterly Assets of $5.8 million for Q1 2026, up 40.27% on a QoQ basis from $4.1 million in Q4 2025.

20 (AIDX) has 3 years of Assets data on file, last reported at $5.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Assets changed N/A year-over-year to $5.8 million; the trailing twelve-month figure through Mar 2026 stood at $5.8 million (changed N/A YoY), and the FY2025 full-year result was $4.1 million, up 15.43% from the prior year.
  • Assets for Q1 2026 stood at $5.8 million, up from $4.1 million in the prior quarter.
  • Across five years, Assets topped out at $5.8 million in Q1 2026 and bottomed at $3.6 million in Q4 2024.
  • The 3-year median for Assets is $4.1 million (2025), against an average of $4.5 million.
  • Peak annual rise in Assets reached 15.43% in 2025, while the deepest fall reached 15.43% in 2025.
  • A 3-year view of Assets shows it stood at $3.6 million in 2024, then climbed by 15.43% to $4.1 million in 2025, then jumped by 40.27% to $5.8 million in 2026.
  • The last three Assets figures came in at $5.8 million (Q1 2026), $4.1 million (Q4 2025), and $3.6 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 110.43 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 46.29 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 37.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 10.74 Bn
10 20 - - 62,884.00 5.80 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.80 Mn
Dec 31, 2025 4.14 Mn
Dec 31, 2024 3.58 Mn